Janos Geli

704 total citations
16 papers, 537 citations indexed

About

Janos Geli is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Janos Geli has authored 16 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Janos Geli's work include Cancer, Hypoxia, and Metabolism (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Epigenetics and DNA Methylation (4 papers). Janos Geli is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Epigenetics and DNA Methylation (4 papers). Janos Geli collaborates with scholars based in Sweden, United States and United Kingdom. Janos Geli's co-authors include Martin Bäckdahl, Catharina Larsson, Anders Höög, David Velázquez‐Fernández, Nimrod Kiss, Joakim Lundeberg, Bertil Hamberger, Magnus Kjellman, Peter Nilsson and Dirk M. Maybauer and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Janos Geli

16 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janos Geli Sweden 14 230 216 184 111 102 16 537
Luis Ramón Spain 17 234 1.0× 74 0.3× 208 1.1× 262 2.4× 21 0.2× 31 885
Monique Silvy France 13 78 0.3× 84 0.4× 134 0.7× 27 0.2× 137 1.3× 30 516
Kathleen Pappritz Germany 15 44 0.2× 192 0.9× 289 1.6× 197 1.8× 20 0.2× 31 757
Paul H.M.H. Theunissen Netherlands 12 58 0.3× 115 0.5× 145 0.8× 41 0.4× 13 0.1× 21 505
T Takizawa Japan 11 104 0.5× 330 1.5× 169 0.9× 76 0.7× 20 0.2× 16 702
Emilie Castermans Belgium 14 30 0.1× 77 0.4× 138 0.8× 327 2.9× 114 1.1× 21 626
Vivienne Tobias Australia 13 61 0.3× 194 0.9× 109 0.6× 31 0.3× 47 0.5× 24 581
Yang Seok Chae South Korea 13 39 0.2× 120 0.6× 91 0.5× 34 0.3× 40 0.4× 32 482
Peter Schick Germany 10 119 0.5× 129 0.6× 45 0.2× 106 1.0× 61 0.6× 35 459
K Shinmyozu Japan 8 74 0.3× 125 0.6× 51 0.3× 75 0.7× 7 0.1× 28 651

Countries citing papers authored by Janos Geli

Since Specialization
Citations

This map shows the geographic impact of Janos Geli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janos Geli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janos Geli more than expected).

Fields of papers citing papers by Janos Geli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janos Geli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janos Geli. The network helps show where Janos Geli may publish in the future.

Co-authorship network of co-authors of Janos Geli

This figure shows the co-authorship network connecting the top 25 collaborators of Janos Geli. A scholar is included among the top collaborators of Janos Geli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janos Geli. Janos Geli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Geli, Janos, Massimo Capoccia, Dirk M. Maybauer, & Marc O. Maybauer. (2022). Direct Thrombin Inhibition in Extracorporeal Membrane Oxygenation. The International Journal of Artificial Organs. 45(7). 652–655. 9 indexed citations
2.
Geli, Janos, Massimo Capoccia, Dirk M. Maybauer, & Marc O. Maybauer. (2021). Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review. Journal of Intensive Care Medicine. 37(4). 459–471. 34 indexed citations
3.
Geli, Janos, Massimo Capoccia, Dirk M. Maybauer, & Marc O. Maybauer. (2020). Argatroban anticoagulation for adult Extracorporeal Membrane Oxygenation: A systematic review. Research Square. 3 indexed citations
4.
Kiss, Nimrod, Andreas Muth, Adam Andreasson, et al.. (2012). Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation. Endocrine Related Cancer. 20(1). 65–78. 15 indexed citations
5.
Kiss, Nimrod, Per Kogner, John Inge Johnsen, et al.. (2012). Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas. BMC Medical Genetics. 13(1). 83–83. 21 indexed citations
6.
Velázquez‐Fernández, David, Kristina Lindsten, C. Christofer Juhlin, et al.. (2009). Transcriptional profiling enables molecular classification of adrenocortical tumours. European Journal of Endocrinology. 161(1). 141–152. 55 indexed citations
7.
Geli, Janos, Nimrod Kiss, Mohsen Karimi, et al.. (2008). Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior. Clinical Cancer Research. 14(9). 2551–2559. 47 indexed citations
8.
Kiss, Nimrod, Janos Geli, Frida E. Lundberg, et al.. (2008). Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas. Endocrine Related Cancer. 15(2). 609–621. 20 indexed citations
9.
Geli, Janos, Per Kogner, Fredrik Lanner, et al.. (2008). Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. International Journal of Cancer. 123(2). 389–394. 13 indexed citations
10.
Geli, Janos, Nimrod Kiss, Fredrik Lanner, et al.. (2007). The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. Endocrine Related Cancer. 14(1). 125–134. 24 indexed citations
11.
Foukakis, Theodoros, Amy Au, Göran Wallin, et al.. (2006). The Ras EffectorNORE1AIs Suppressed in Follicular Thyroid Carcinomas with aPAX8-PPARγ Fusion. The Journal of Clinical Endocrinology & Metabolism. 91(3). 1143–1149. 25 indexed citations
12.
Buckley, Patrick G., Arkadiusz Piotrowski, Kiran K. Mantripragada, et al.. (2005). Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array‐CGH. International Journal of Cancer. 118(5). 1159–1164. 17 indexed citations
13.
Velázquez‐Fernández, David, Janos Geli, Anders Höög, et al.. (2005). Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery. 138(6). 1087–1094. 107 indexed citations
14.
Geli, Janos, Brita Nord, Tony Frisk, et al.. (2005). Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. International Journal of Oncology. 26(5). 1385–91. 21 indexed citations
15.
Pár, Gabriella, Janos Geli, Noémi Kozma, P. Várga, & Júlia Szekeres‐Barthó. (2003). Progesterone Regulates IL12 Expression in Pregnancy Lymphocytes by Inhibiting Phospholipase A2. American Journal of Reproductive Immunology. 49(1). 1–5. 45 indexed citations
16.
Zhao, Yaofeng, Imre Kacskovıcs, Qiang Pan‐Hammarström, et al.. (2002). Artiodactyl IgD: The Missing Link. The Journal of Immunology. 169(8). 4408–4416. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026